Selecta Biosciences Current Assets

Selecta Biosciences (SELB) currently reports a current assets of $130M as of September 2026. That compares with $150M in the prior-year period — down 10.7% year over year. Use the charts on this page to explore Selecta Biosciences's current assets history and peer comparisons.

Selecta Biosciences's current assets decreased from $150M to $130M — a 10.7% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Selecta Biosciences reported $130M in current assets as of September 2026. That compares with $150M in the prior-year period — down 10.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Selecta Biosciences, and consider following SELB for alerts when major investors trade the stock.

Selecta Biosciences is classified in the Healthcare sector. On current assets, it currently shows $130M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SELB with unrelated industries.